LIEN Earnings

LIEN reported its earnings on 2026-05-14, showcasing a revenue of 16.70M against an estimate of 14.21M, resulting in a 17.54% surprise. The EPS was 0.44, surpassing the expected 0.36 by 22.22%. The stock experienced a 8.38% price change on the earnings day and a 7.94% change over the next five days, reflecting market reactions to the results.

Following LIEN's earnings announcement on 2026-05-14, the stock price moved by 8.38% on the day of the release. Over the subsequent five days, it saw a 7.94% change. Historically, LIEN's stock price tends to shift by an average of -1.65% in the 10 days leading up to earnings and 4.01% in the 10 days following, providing insight into potential market.

For , analysts estimate LIEN's annual revenue to reach undefined, while the EPS is projected at undefined. These estimates reflect recent revisions, with revenue estimates revised downward by -2.25% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between LIEN's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for were revised downward by -2.25%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, LIEN's stock price typically moves by -1.65% in the 10 days before its earnings and 4.01% in the 10 days after. For the upcoming earnings, analysts expect an EPS of undefined and revenue of undefined.

The earnings call shows mixed signals: strong financial performance with increased net investment and gross income, consistent dividends, and a solid pipeline. However, risks in the cannabis market, regulatory uncertainties, and unrealized losses pose challenges. Management's vague responses about the $500 million shelf registration also add uncertainty. The Q&A session highlighted both positive M&A prospects and concerns about execution risks. Overall, the sentiment is balanced between positive financial metrics and potential regulatory and market risks, leading to a neutral stock price prediction.